Fidelity Investments
STTK icon

Fidelity Investments’s Shattuck Labs STTK Stock Holding History

Fidelity Investments’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Buy
392,596
+96
+0% +$599 ﹤0.01% 2644
2026
Q1 		$2.52M Sell
392,500
-100
-0% -$474 ﹤0.01% 2561
2025
Q4 		$1.43M Buy
392,600
+389,233
+11,560% +$929K ﹤0.01% 2717
2025
Q3 		$8.05K Sell
3,367
-5,071
-60% -$6.21K ﹤0.01% 4669
2025
Q2 		$6.68K Sell
8,438
-1,778
-17% -$1.72K ﹤0.01% 4637
2025
Q1 		$9.71K Buy
10,216
+3,937
+63% +$4.85K ﹤0.01% 4511
2024
Q4 		$7.6K Sell
6,279
-7,152,811
-100% -$8.86M ﹤0.01% 4549
2024
Q3 		$25M Buy
7,159,090
+26,460
+0.4% +$98.6K ﹤0.01% 1634
2024
Q2 		$27.5M Buy
7,132,630
+11,483
+0.2% +$93.4K ﹤0.01% 1537
2024
Q1 		$63.7M Buy
7,121,147
+49,973
+0.7% +$458K ﹤0.01% 1228
2023
Q4 		$50.4M Buy
7,071,174
+736,894
+12% +$2.01M ﹤0.01% 1287
2023
Q3 		$9.63M Sell
6,334,280
-36,413
-0.6% -$83.1K ﹤0.01% 1836
2023
Q2 		$19.9M Buy
6,370,693
+3,330
+0.1% +$9.66K ﹤0.01% 1636
2023
Q1 		$18.7M Buy
6,367,363
+8,776
+0.1% +$31K ﹤0.01% 1631
2022
Q4 		$14.6M Buy
6,358,587
+1,286
+0% +$3.22K ﹤0.01% 1745
2022
Q3 		$17.2M Buy
6,357,301
+409
+0% +$1.53K ﹤0.01% 1663
2022
Q2 		$25.8M Buy
6,356,892
+2,360
+0% +$8.54K ﹤0.01% 1552
2022
Q1 		$27.1M Buy
6,354,532
+17,552
+0.3% +$99.5K ﹤0.01% 1649
2021
Q4 		$53.9M Buy
6,336,980
+18,564
+0.3% +$256K ﹤0.01% 1398
2021
Q3 		$129M Buy
6,318,416
+32,549
+0.5% +$696K 0.01% 994
2021
Q2 		$182M Buy
6,285,867
+19,503
+0.3% +$570K 0.01% 865
2021
Q1 		$183M Buy
6,266,364
+4,729
+0.1% +$199K 0.02% 824
2020
Q4 		$317M Buy
+6,261,635
New +$201M 0.03% 558

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments's STTK Position: Q2 2026 in Review

Fidelity Investments increased its Shattuck Labs (STTK) stake by 0.02% in Q2 2026, buying an estimated $599 and bringing the position to 392,596 shares worth $2.72M. The position accounts for ﹤0.01% of the portfolio, ranked #2644.

Fidelity Investments first reported a position in STTK in Q4 2020 and has held it in 23 quarters since. The position peaked at $317M in Q4 2020. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • Fidelity Investments held 392,596 shares of Shattuck Labs worth $2.72M as of Q2 2026.
  • Fidelity Investments bought 96 Shattuck Labs shares in Q2 2026, an estimated $599.
  • Shattuck Labs made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2644 holding.
  • Fidelity Investments first reported a position in Shattuck Labs in Q4 2020 and has held it in 23 quarters since.
  • Fidelity Investments's Shattuck Labs position peaked at $317M in Q4 2020.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.